Cited by 171Science, Research, and MedicineArtificial Intelligence in Healthcare and EducationTechnology and Human Factors in Education and Health

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Promises, promises, and precision medicine

Open access

Joyner, Michael J., Paneth, Nigel·2019·Journal of Clinical Investigation

DOI 10.1172/jci126119PMC PMC6391102

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci126119

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Le Tourneau, C., Delord, J.-P., Gonçalves, A., Gavoille, C., Dubot, C., Isambert, N., Campone, M., Trédan, O., Massiani, M.-A., Mauborgne, C., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00188-6 · Cited by 1,137
Medical and Ethical Consequences of the Human Genome Project
Collins, F. S. (1991) · The Journal of Clinical Ethics · doi:10.1086/jce199102411 · Cited by 663
Medical and Societal Consequences of the Human Genome Project
Collins, F. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410106 · Cited by 586
Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies
Pesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis
Hollands, G. J., French, D., Griffin, S. J., Prevost, A. T., Sutton, S. R., King, S., & Marteau, T. M. (2016) · BMJ · doi:10.1136/bmj.i1102 · Cited by 499
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
Marquart, J. P., Chen, E. Y.-S., & Prasad, V. K. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1660 · Cited by 386
Functional precision cancer medicine—moving beyond pure genomics
Letai, A. (2017) · Nature Medicine · doi:10.1038/nm.4389 · Cited by 366
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
Scannell, J. W., & Bosley, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147215 · Cited by 279
Genotype-Guided vs Clinical Dosing of Warfarin and Its Analogues
Stergiopoulos, K., & Brown, D. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2368 · Cited by 125
Predicting Polygenic Obesity Using Genetic Information
Loos, R. J. F., & Janssens, A. C. J. W. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.013 · Cited by 120

Show all 18 references

Research works printed but not linked: 1

Francis S. Collins (@NIHDirector), “I am here at the #JoinAllofUs Twitter chat! Ask me questions on #PrecisionMedicine & the @AllofUsResearch Program for the next 30 minutes,” Twitter, May 8, 2018, 10:31 am, https://twitter.com/nihdirector/status/993906139036356608 Accessed December 20, 2018

Sorted by citations

Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Piché, M., Tchernof, A., & Després, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.316101 · Cited by 2,133
The ‘Digital Twin’ to enable the vision of precision cardiology
Acero, J. C., Margara, F., Marciniak, M., Rodero, C., Lončarić, F., Feng, Y., Gilbert, A., Fernandes, J. F., Bukhari, S. H. A., Wajdan, A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa159 · Cited by 987
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
Rolfo, C., Mack, P., Scagliotti, G. V., Aggarwal, C., Arcila, M. E., Barlesi, F., Bivona, T., Diehn, M., Dive, C., Dziadziuszko, R., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.06.017 · Cited by 683
Radiomics: from qualitative to quantitative imaging
Rogers, W., Seetha, S. T., Refaee, T., Lieverse, R. I. Y., Granzier, R. W. Y., Ibrahim, A., Keek, S. A., Sanduleanu, S., Primakov, S. P., Beuque, M. P. L., et al. (2020) · British Journal of Radiology · doi:10.1259/bjr.20190948 · Cited by 391
Precision Medicine: Disease Subtyping and Tailored Treatment
Wang, R. C., & Wang, Z. (2023) · Cancers · doi:10.3390/cancers15153837 · Cited by 354
Data Integration Challenges for Machine Learning in Precision Medicine
Martínez-García, M., & Hernández-Lemus, E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.784455 · Cited by 185
Artificial Intelligence in Oncology: Current Capabilities, Future Opportunities, and Ethical Considerations
Shreve, J. T., Khanani, S. A., & Haddad, T. C. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_350652 · Cited by 151
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
Sadri, A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01737 · Cited by 149
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa034 · Cited by 125
Complementopathies and precision medicine
Gavriilaki, E., & Brodsky, R. A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136094 · Cited by 109
The application of big data to cardiovascular disease: paths to precision medicine
Leopold, J. A., Maron, B. A., & Loscalzo, J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129203 · Cited by 106
Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
Wu, C., Zhao, Y. L., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., Wang, Y., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.011 · Cited by 88
The Use and Ethics of Digital Twins in Medicine
Iqbal, J. D., Krauthammer, M. O., & Biller‐Andorno, N. (2022) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2022.97 · Cited by 83
NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
Tao, W., Tian, G., Xu, S., Li, J., Zhang, Z., & Li, J. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02124-2 · Cited by 76
Mouse Systems Genetics as a Prelude to Precision Medicine
Li, H., & Auwerx, J. H. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.01.004 · Cited by 72
The changing landscape of cancer in the USA — opportunities for advancing prevention and treatment
Islami, F., Siegel, R. L., & Jemal, A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0378-y · Cited by 65
Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Olivier, T., Fernández, E., Labidi‐Galy, S. I., Dietrich, P., Rodríguez-Bravo, V., Baciarello, G., Fizazi, K. S., & Patrikidou, A. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102204 · Cited by 57
Escape from senescence: molecular basis and therapeutic ramifications
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023) · The Journal of Pathology · doi:10.1002/path.6164 · Cited by 57
What are the chances for personalised treatment with antidepressants? Detection of patient-by-treatment interaction with a variance ratio meta-analysis
Plöderl, M., & Hengartner, M. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-034816 · Cited by 50
Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson’s disease
Carling, P. J., Mortiboys, H., Green, C., Mihaylov, S. R., Sandor, C., Schwartzentruber, A., Taylor, R. N., Wei, W., Hastings, C., Wong, S. L., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101772 · Cited by 49
Precision Medicine—Are We There Yet? A Narrative Review of Precision Medicine’s Applicability in Primary Care
Evans, W. R. H., Meslin, E. M., Kai, J., & Qureshi, N. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040418 · Cited by 50
Advancement of Organoid Technology in Regenerative Medicine
Arjmand, B., Rabbani, Z. H., Soveyzi, F., Tayanloo-Beik, A., Rezaei–Tavirani, M., Biglar, M., Adibi, H., & Larijani, B. A. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-022-00271-0 · Cited by 47
The ethical challenges of personalized digital health
Maeckelberghe, E. L. M., Zdunek, K., Marceglia, S. R. F., Farsides, B., & Rigby, M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1123863 · Cited by 46
Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders
Lenze, E. J., Nicol, G. E., Barbour, D. L., Kannampallil, T., Wong, A. W. K., Piccirillo, J., Drysdale, A. T., Sylvester, C. M., Haddad, R., Miller, J. P., et al. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200042 · Cited by 43
Current challenges and future directions of ATMPs in regenerative medicine
Kakroodi, F. A., Khodadoust, E., Alizadeh, M., Tehrani, R. S. H., Sarabi, P. A., Rahmanian, M., & Vosough, M. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.06.017 · Cited by 47
The Development of a Personalised Training Framework: Implementation of Emerging Technologies for Performance
Pickering, C., & Kiely, J. (2019) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk4020025 · Cited by 48
Novel phylogenetic methods are needed for understanding gene function in the era of mega-scale genome sequencing
Nagy, L. G., Merényi, Z., Hegedüs, B., & Bálint, B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1241 · Cited by 43
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
Stenzinger, A., Edsjö, A., Ploeger, C., Friedman, M., Fröhling, S., Wirta, V., Seufferlein, T. T. W., Botling, J., Duyster, J., Akhras, M. S., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.026 · Cited by 43
Application of nanomaterials in proteomics-driven precision medicine
Zhang, Y., Yang, H., Yu, Y., & Zhang, Y. (2022) · Theranostics · doi:10.7150/thno.64325 · Cited by 39
Potential of Whole-Genome Sequencing-Based Pharmacogenetic Profiling
Caspar, S. M., Schneider, T., Stoll, P., Meienberg, J., & Mátyás, G. (2021) · Pharmacogenomics · doi:10.2217/pgs-2020-0155 · Cited by 37
Molecular screening to select therapy for advanced cancer?
Tannock, I. F., & Hickman, J. A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz088 · Cited by 35
Genetic Approaches for Sports Performance: How Far Away Are We?
Joyner, M. J. (2019) · Sports Medicine · doi:10.1007/s40279-019-01164-z · Cited by 33
Self-citation
Engineering Person-Specific Behavioral Interventions to Promote Physical Activity
Conroy, D. E., Lagoa, C. M., Hekler, E. B., & Rivera, D. E. (2020) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000232 · Cited by 37
Polygenic risk scores and the prediction of common diseases
Ala‐Korpela, M., & Holmes, M. V. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz254 · Cited by 32
Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
Gavriilaki, M., Kimiskidis, V. Κ., & Gavriilaki, E. (2020) · Pharmaceuticals · doi:10.3390/ph13110341 · Cited by 32
Metaboloepigenetics in cancer, immunity, and cardiovascular disease
Keating, S. T., & El‐Osta, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac058 · Cited by 29
Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy
Liu, Y., Xia, X., Zheng, M., & Shi, B. (2024) · Advanced Materials · doi:10.1002/adma.202314354 · Cited by 31
Race, science and (im)precision medicine
Adigbli, G. (2020) · Nature Medicine · doi:10.1038/s41591-020-1115-x · Cited by 28
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes
Bizzarri, M., Fedeli, V., Monti, N., Cucina, A., Jalouli, M., Alwasel, S. H., & Harrath, A. H. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00254-1 · Cited by 27
Native American medicine in the treatment of chronic illness: developing an integrated program and evaluating its effectiveness.
Mehl‐Madrona, L. (1999) · PubMed · Cited by 25
Addressing biomedical data challenges and opportunities to inform a large-scale data lifecycle for enhanced data sharing, interoperability, analysis, and collaboration across stakeholders
Sriram, V., Conard, A. M., Rosenberg, I., Kim, D., Saponas, T. S., & Hall, A. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-90453-x · Cited by 27
Key Points in Remote-Controlled Drug Delivery: From the Carrier Design to Clinical Trials
Voronin, D. V., Abalymov, A. A., Svenskaya, Y. I., & Lomova, M. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179149 · Cited by 26
Properties of Life
Rosslenbroich, B. (2023) · The MIT Press eBooks · doi:10.7551/mitpress/14739.001.0001 · Cited by 25
Precision Medicine and Exercise Therapy in Duchenne Muscular Dystrophy
Kostek, M. C. (2019) · Sports · doi:10.3390/sports7030064 · Cited by 22
Advancing human health in the decade ahead: pregnancy as a key window for discovery
Sadovsky, Y., Mesiano, S. A., Burton, G. J., Lampl, M., Murray, J. C., Freathy, R. M., Mahadevan-Jansen, A. M., Moffett, A., Price, N. D., Wise, P. H., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.031 · Cited by 22
Self-citation
Post-Pandemic Drug Discovery and Development: Facing Present and Future Challenges
Villoutreix, B. O. (2021) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2021.728469 · Cited by 23
N-of-1 trials: The epitome of personalized medicine?
Samuel, J. P., Wootton, S. H., & Tyson, J. E. (2023) · Journal of Clinical and Translational Science · doi:10.1017/cts.2023.583 · Cited by 19
Pharmacogenetics in psychiatric care, a call for uptake of available applications
Lunenburg, C. A. T. C., & Gasse, C. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113336 · Cited by 20
Personalized Medicine in Infertile Men
Garrido, N., & Hervás, I. (2020) · Urologic Clinics of North America · doi:10.1016/j.ucl.2019.12.011 · Cited by 18
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
Nigro, M. C., Marchese, P. V., Deiana, C., Casadio, C., Galvani, L., Federico, A. D., & Giglio, A. D. (2023) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s388047 · Cited by 19
Machine Learning based Psychology: Advocating for A Data-Driven Approach
Velez, J. I. (2021) · International journal of psychological research · doi:10.21500/20112084.5365 · Cited by 23
Is Cancer Reversible? Rethinking Carcinogenesis Models—A New Epistemological Tool
Pensotti, A., Bertolaso, M., & Bizzarri, M. (2023) · Biomolecules · doi:10.3390/biom13050733 · Cited by 18
When does precision matter? Personalized medicine from the perspective of public health
Wilson, J. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0013 · Cited by 17
Eating Behavior and the Evolutionary Perspective on Anorexia Nervosa
Södersten, P., Brodin, U., Zandian, M., & Bergh, C. E. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00596 · Cited by 16
How the human genome transformed study of rare diseases
Alkuraya, F. S. (2021) · Nature · doi:10.1038/d41586-021-00294-7 · Cited by 15
Can precision medicine be personal; Can personalized medicine be precise?
(2022) · doi:10.1093/oso/9780198863465.001.0001 · Cited by 16
Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting Strategies
Mirzayans, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060322 · Cited by 13
When will individuals meet their personalized probabilities? A philosophical note on risk prediction
Dekkers, O. M., & Mulder, J. M. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00700-w · Cited by 13
Co-emergence and Collapse: The Mesoscopic Approach for Conceptualizing and Investigating the Functional Integration of Organisms
Bizzarri, M., Giuliani, A., Pensotti, A., Ratti, E., & Bertolaso, M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00924 · Cited by 13
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer
Al-Obeidi, E., Riess, J. W., Malapelle, U., Rolfo, C. D., & Gandara, D. R. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2023.02.005 · Cited by 12
Precision medicine and health disparities: The case of pediatric acute lymphoblastic leukemia
Burke, W., & Thummel, K. E. (2019) · Nursing Outlook · doi:10.1016/j.outlook.2019.05.003 · Cited by 11
Artificial Intelligence in Precision Medicine: A Perspective in Biomarker and Drug Discovery
Santoshi, S., & Sengupta, D. (2021) · Springer eBooks · doi:10.1007/978-981-16-0811-7_4 · Cited by 11
The advent of automated medicine? The values and meanings of precision
Prainsack, B. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0015 · Cited by 11
Digital Twin Technology - Fundamentals and Applications
Korhan, O. (2023) · Industrial engineering and management. · doi:10.5772/intechopen.104048 · Cited by 11
CRISPR—a challenge for national and international regulation
Nicol, D. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0014 · Cited by 9
The future of personalized medicine in Saudi Arabia
Mawkili, W. (2025) · Saudi Medical Journal · doi:10.15537/smj.2025.46.1.20240700 · Cited by 9
The precision paradox
Vogt, H. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0005 · Cited by 11
Perspective Chapter: Digital Twins for Health – Opportunities, Barriers and a Path Forward
Armeni, P., Polat, I., Rossi, L. M. D., Diaferia, L., Visioli, G., Meregalli, S., & Gatti, A. M. (2023) · Industrial engineering and management. · doi:10.5772/intechopen.112490 · Cited by 9
Calcium isotope composition in serum and urine for the assessment of bone mineral balance (BMB) – The Osteolabs post-market follow-up study
Eisenhauer, A., Hastuti, A. A. M. B., Heuser, A., Kolevica, A., Brandt, B., Shroff, R. C., Oehme, J., & Müller, M. (2024) · Bone · doi:10.1016/j.bone.2024.117210 · Cited by 9
Personalized nutrition: aligning science, regulation, and marketing
Rogus, S., & Lurie, P. G. (2024) · Health Affairs Scholar · doi:10.1093/haschl/qxae107 · Cited by 8
Precision medicine in an imprecise and complex world: Magic bullets, hype, and the fuzzy line between health and disease
Aron, D. C. (2019) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13306 · Cited by 9
Preventive Cardiology and Risk Assessment: Beyond LDL
Goyal, A., & Cho, L. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00876-2 · Cited by 8
Experimental pharmacology in precision medicine
Urbaniak, A. J., Thummel, K. E., Alade, A. N., Rettie, A. E., Prasad, B., Nicolò, A. D., Martin, J. H., Sheppard, D. N., & Jarvis, M. F. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1147 · Cited by 7
The Clinical Immunogenomics Research Consortium Australasia (CIRCA): a Distributed Network Model for Genomic Healthcare Delivery
CIRCA, O. B. O., Phan, T. G., Gray, P. E., Wong, M., Macintosh, R., Burnett, L., & Tangye, S. G. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00787-6 · Cited by 7
Precision Medicine: Lessons Learned From Implementation of a Pharmacogenetics‐Based Patient Care Program in a Real‐World Setting
Kim, R. B. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1611 · Cited by 7
The Impact of Big Data Analytics on Health Care: A Systematic ReviewPreprint
Akour, I. A., & Salloum, S. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4995748/v1 · Cited by 9
When Therapy-Induced Cancer Cell Apoptosis Fuels Tumor Relapse
Mirzayans, R. (2024) · Onco · doi:10.3390/onco4010003 · Cited by 6
A novel nomogram model based on Ki-67 characteristic expression to predict prognosis in head and neck squamous cell carcinoma
Wang, T., Xue, L., Li, Z., Hong, Z., Hu, N., Li, Y., & Yan, B. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1376498 · Cited by 6
Playing the genome card
Berkowitz, A. (2019) · Journal of Neurogenetics · doi:10.1080/01677063.2019.1706093 · Cited by 6
Metronomic dose-finding approach in oral chemotherapy by experimentally-driven integrative mathematical modeling.
Kweon, S., Jeong, Y.-S., Chung, S.-W., Lee, H., Lee, H.-K., Park, S., Choi, J. U., Park, J., Chung, S., & Byun, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121584 · Cited by 6
Genome-wide association study of the risk of chronic kidney disease and kidney-related traits in the Japanese population: J-Kidney-Biobank
Sugawara, Y., Hirakawa, Y., Nagasu, H., Narita, A., Katayama, A., Wada, J., Shimizu, M., Wada, T., Kitamura, H., Nakano, T., et al. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01094-1 · Cited by 5
Alleviating the public health burden of hypertension: debating precision prevention as a possible solution
Samakosky, M. J., & Norris, S. A. (2024) · Global Health Action · doi:10.1080/16549716.2024.2422169 · Cited by 5
Obviously nine believers: Actionable germline genetic variants for pre‐emptive pharmacogenetic testing
Damkier, P. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13335 · Cited by 5
The ownership paradox: nurturing continuity and change for the future ASCI
Marr, K. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci134851 · Cited by 5
Predictive health index: integrating body composition and heart rate variability metrics with artificial intelligence to predict chronic disease risk and specific chronic non-communicable diseases
Boschiero, D., Gallotta, A., Ferrari, F., Dragoumani, K., Lambrou, G. Ι., Vlachakis, D., & Chrousos, G. P. (2025) · HORMONES · doi:10.1007/s42000-025-00727-2 · Cited by 4
Detection of nucleated red blood cells using the Mindray BC-6800Plus hematology analyzer: a clinical performance evaluation
Wang, N., Jiang, J., Wang, J., He, Y., Wen, N., Liu, Y., Wang, Y., Li, H., & Shi, P. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1772 · Cited by 4
Editorial: Radiomics Advances Precision Medicine
Gao, B., Dong, D., Zhang, H., Liu, Z., Payabvash, S., & Chen, B. T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.853948 · Cited by 4
Trends and developments in health systems modeling: a bibliometric analysis
Maguraushe, K., Ndayizigamiye, P., & Bokaba, T. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1595310 · Cited by 3
What Is Apoptosis and Why Is It Inhibited by the Most Important Tumor Suppressor (p53)?
Mirzayans, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110505 · Cited by 3
Environmental considerations in human genomic data governance: overcoming normative challenges
Ghinea, N., Xin, W., Samuel, G. N., Lucassen, A., & Newson, A. J. (2026) · BMC Medical Ethics · doi:10.1186/s12910-026-01417-3 · Cited by 4
Network-Driven Drug Discovery
Wray, J., & Whitmore, A. V. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_7 · Cited by 3
The problematic side of precision medicine
Boniolo, G. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0004 · Cited by 3
Personalization, individuation, and the ethos of precision medicine
Barilan, Y. M. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0007 · Cited by 3
Convalescent Plasma and the US Expanded Access Program: A Personal Narrative
Joyner, M. J. (2024) · Current topics in microbiology and immunology · doi:10.1007/82_2024_269 · Cited by 3
Self-citation
P7 medicine: Humanizing systems medicine
Marcum, J. A. (2021) · Dialnet (Universidad de la Rioja) · Cited by 3
Novel Clinical Trial Designs in Pursuit of Precision Oncology: Lung-MAP As a Model
Riess, J. W., Rolfo, C. D., & Gandara, D. R. (2021) · Clinical Lung Cancer · doi:10.1016/j.cllc.2021.03.013 · Cited by 3
The Complexity of Tumor Heterogeneity: Limitations and Challenges of the Pharmacogenomics in Cancer Treatment
Militello, G., & Bertolaso, M. (2022) · Human perspectives in health sciences and technology · doi:10.1007/978-3-030-74804-3_2 · Cited by 4
Potential challenges to doctor–patient trust posed by personalized medicine
Cohen, S. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0012 · Cited by 2
What 21st century medicine should be—history, vision, implementation, and opportunities
Hood, L., Price, N. D., & Evans, S. J. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0003 · Cited by 2
Thoughtful genomics
Reardon, J. (2022) · Oxford University Press eBooks · doi:10.1093/oso/9780198863465.003.0016 · Cited by 2

Authors: Joyner, M. J., & Paneth, N.
Affiliations: Mayo Clinic (US)
Michigan State University (US)
Corresponding author: Paneth, Nigel
ORCID: Joyner, Michael J.
Paneth, Nigel
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2019-01-28
Volume: 129
Issue: 3
Pages: 946-948
ISSN: 0021-9738 (ISSN-L)
1558-8238
DOI: 10.1172/jci126119
PMC: PMC6391102
OpenAlex: W2911598022
Cited by: 171
References: 18
Citations by year: 2026: 7 · 2025: 15 · 2024: 22 · 2023: 24 · 2022: 35 · 2021: 30 · 2020: 19 · 2019: 18
FWCI: 24.39
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Technology and Human Factors in Education and Health
Keywords: precision medicine, personalized medicine
MeSH terms: Clinical Decision-Making, Humans, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Promises, promises, and precision medicine

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks